Abbvie Inc

The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. Abbvie Inc is not very popular among insiders. Abbvie Inc is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sal...

News

A migraine drug ad featuring Serena Williams got called out by the FDA
A migraine drug ad featuring Serena Williams got called out by the FDA

Quartz The U.S. Food and Drug Administration (FDA) reprimanded AbbVie (ABBV) over an ad for its migraine medication, Ubrelvy, that featured tennis star Serena Williams.Read more...\n more…

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Zacks Investment Research AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near...\n more…

Abbvie's Botox launches for wide jaw appearance in China
Abbvie's Botox launches for wide jaw appearance in China

Seeking Alpha - Healthcare Abbvie's Botox launches for wide jaw appearance in China...\n more…

AbbVie slaps BeiGene with another blood cancer lawsuit, this time on BTK degrader trade secrets
AbbVie slaps BeiGene with another blood cancer lawsuit, this time on BTK degrader trade secrets

FierceBiotech.com - Biotech AbbVie slaps BeiGene with another blood cancer lawsuit, this time on BTK degrader trade secrets\nfkansteiner\nWed, 09/11/2024 - 10:21...\n more…

2,584 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by LGT Fund Management Co Ltd.
2,584 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by LGT Fund Management Co Ltd.

Ticker Report LGT Fund Management Co Ltd. purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm...\n more…

AbbVie's Allergan Aesthetics launches Botox for MMP in China
AbbVie's Allergan Aesthetics launches Botox for MMP in China

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…